| COVID-19 mechanisms in the human body—What we know so far A Kumar, RK Narayan, P Prasoon, C Kumari, G Kaur, S Kumar, ... Frontiers in immunology 12, 693938, 2021 | 78 | 2021 |
| COVID-19 pandemic: insights into molecular mechanisms leading to sex-based differences in patient outcomes A Kumar, RK Narayan, M Kulandhasamy, P Prasoon, C Kumari, S Kumar, ... Expert Reviews in Molecular Medicine 23, e7, 2021 | 20 | 2021 |
| Pathogenesis guided therapeutic management of COVID-19: an immunological perspective A Kumar, P Prasoon, PS Sekhawat, V Pareek, MA Faiq, C Kumari, ... International Reviews of Immunology 40 (1-2), 54-71, 2021 | 13 | 2021 |
| Mecanismos del COVID-19 en el cuerpo humano: Lo que sabemos hasta ahora A Kumar, RK Narayan, P Prasoon, C Kumari, G Kaur, S Kumar, ... Kompass Neumología 4 (1), 3-20, 2022 | 8 | 2022 |
| Indian society of hematology and blood transfusion (ISHBT) consensus document on hematological practice during COVID-19 pandemic R Kar, TK Dolai, PS Shekhawat, P Malhotra, A Singh, R Naithani, ... Indian Journal of Hematology and Blood Transfusion 37, 1-9, 2021 | 2 | 2021 |
| Profile of autoimmune haemolytic anaemia: analysis of 10 years data from a hematology center in eastern India A Baveja, PK Mandal, A Chattopadhyay, M Garg, PS Shekhawat, TK Dolai Asian Hematology Research Journal 4 (3), 33-43, 2021 | 1 | 2021 |
| Host Vulnerability Factors Affecting Patient Outcomes in COVID-19: An Update A Kumar, K Sesham, RK Narayan, P Prasoon, C Kumari, S Kumar, ... Available at SSRN 3769784, 2021 | 1 | 2021 |
| Clinicopathological characteristics and outcome in patients of primary CNS lymphoma treated with modified de-angelis protocol: an audit D Podder, SJ Bhave, PS Shekhawat, R Nair Clinical Lymphoma Myeloma and Leukemia 18, S279-S280, 2018 | 1 | 2018 |
| Telemedicine in hematology; long-term implications of a short-term experience during COVID-19 pandemic PK Mandal, PS Shekhawat Journal of Hematology and Allied Sciences 1 (2), 54-58, 2021 | | 2021 |
| Bone infarct (osteonecrosis) as late side effect of steroid in acute lymphoblastic leukemia survivor PS Shekhawat, M Garg, TK Dolai Journal of Hematology and Allied Sciences 1 (1), 38-40, 2021 | | 2021 |
| Myeloid sarcoma: experience from a hematology care centre of Eastern India A Baveja, PK Mandal, M Garg, PS Shekhawat, S Mitra, A Chattopadhyay, ... Journal of Hematology and Allied Sciences 1 (1), 33-37, 2021 | | 2021 |
| Acute Promyelocytic Leukemia: A Decade Long Experience with Evolving Treatment Strategies PS Shekhawat, PK Mandal, M Garg, A Baveja, TK Dolai Asian Hematology Research Journal 4 (3), 24-32, 2021 | | 2021 |
| Azacitidine Causing Generalised Skin Rash: A Rare Side Effect Shekhawat, Prakash Singh and Mandal, Prakas Kumar and Garg, Malini and Dolai ... Available at SSRN 3627535, 2020 | | 2020 |
| CARE IN CRISIS: MANAGEMENT OF HEMATOLOGY PATIENTS DURING COVID 19 PANDEMIC TKD Prakas K Mandal, Prakash S. Shekhawat wjpmr 6 (9), 95-101, 2020 | | 2020 |
| Institutional Sensitivity Pattern Guides Initial Antimicro-bial Selection in Febrile Neutropenia; Sharing Experience from a Hemato-Oncology Care Center in India M PK, V Karthika, A Bhowmik, S Baul, B Dutta, A Sen, M Jain, ... | | 2020 |
